BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16149635)

  • 1. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():765-7. PubMed ID: 16149635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():803-6. PubMed ID: 20963909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human chorionic gonadotropin beta-core fragment (hCG beta-cf)].
    Okamoto T
    Nihon Rinsho; 1999 Dec; 57 Suppl():586-8. PubMed ID: 10778198
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
    Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
    Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
    Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M; Navaglia F; Basso D; De Paoli M; Nicoletto MO; Maraglino E; Torre GC
    Anticancer Res; 1996; 16(6B):3833-8. PubMed ID: 9042266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of hCG free beta-subunit and beta-core fragment in urine.
    Cole LA
    Prenat Diagn; 1997 Feb; 17(2):185-7. PubMed ID: 9061770
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
    Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary gonadotropin peptide in patients with cancer of digestive organs.
    Motoo Y; Watanabe H; Yamaguchi Y; Mouri I; Fujii T; Yamakawa O; Satomura Y; Okai T; Sawabu N
    Anticancer Res; 1996; 16(4A):2041-8. PubMed ID: 8712740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UGP in urogenital disorders: Egyptian experience.
    el-Ahmady O; Halim AB; Gad M; Walker R
    Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization of urinary beta-core/hCFbetacf: a cause of poor beta-core assay performance in Down syndrome screening studies.
    Iles RK; Butler SA; Jacoby E
    Prenat Diagn; 1999 Aug; 19(8):790-2. PubMed ID: 10451534
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy.
    Hsu JJ; Spencer K; Aitken DA; Crossley J; Choi T; Ozaki M; Tazawa H
    Prenat Diagn; 1999 Feb; 19(2):146-58. PubMed ID: 10215073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K; Shahabi S; Cole L
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic fetoprotein (BFP)].
    Ishii M; Seino Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():629-31. PubMed ID: 16149596
    [No Abstract]   [Full Text] [Related]  

  • 20. New endocrine tumor markers of gynecologic malignancies. A review.
    Kauppila A; Santala M
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):833-7. PubMed ID: 10577610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.